LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1334 | 4267 | 4051 | 1.0533 | 1.0659 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 1334 | 4236 | 4117 | 1.0287 | 1.0352 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1334 | 3883 | 3930 | 0.9878 | 0.9844 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1334 | 3911 | 4051 | 0.9654 | 0.9565 |
BT-20 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1334 | 3700 | 4117 | 0.8986 | 0.8726 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 1334 | 2788 | 3930 | 0.7093 | 0.6043 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 1334 | 2659 | 4051 | 0.6564 | 0.5377 |
BT-20 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 1334 | 2648 | 4117 | 0.6431 | 0.5243 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 1334 | 1234 | 3930 | 0.3139 | -0.0491 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 1334 | 1266 | 4051 | 0.3125 | -0.0324 |
BT-20 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 1334 | 1320 | 4117 | 0.3206 | -0.0068 |
BT-20 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 1334 | 647 | 3930 | 0.1646 | -0.3717 |
BT-20 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 1334 | 581 | 4051 | 0.1434 | -0.4050 |
BT-20 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 1334 | 608 | 4117 | 0.1477 | -0.3835 |
BT-20 | Buparlisib | 10 | uM | LJP5 | 1 | H01 | 72 | hr | 1334 | 430 | 3930 | 0.1094 | -0.5166 |
BT-20 | Buparlisib | 10 | uM | LJP5 | 2 | H01 | 72 | hr | 1334 | 513 | 4051 | 0.1266 | -0.4495 |
BT-20 | Buparlisib | 10 | uM | LJP5 | 3 | H01 | 72 | hr | 1334 | 446 | 4117 | 0.1083 | -0.4905 |
BT-20 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1334 | 4117 | 3930 | 1.0474 | 1.0603 |
BT-20 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 1334 | 4262 | 4051 | 1.0521 | 1.0644 |
BT-20 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 1334 | 4164 | 4117 | 1.0113 | 1.0138 |
BT-20 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 1334 | 4009 | 3930 | 1.0199 | 1.0254 |
BT-20 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 1334 | 4060 | 4051 | 1.0022 | 1.0028 |
BT-20 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 1334 | 3974 | 4117 | 0.9651 | 0.9568 |
BT-20 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 1334 | 3733 | 3930 | 0.9497 | 0.9348 |
BT-20 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 1334 | 3911 | 4051 | 0.9654 | 0.9565 |